#pancreatic cancer

Triple Combo for Pancreatic Cancer

Scientists build on the finding that pancreatic cancer cells use GOT1 to reroute energy and build more cancer cells.

A combination of three immunotherapy drugs shows promise in animal studies.

National Cancer Institute-supported studies are testing ways to pick out people whose diabetes might be a sign of pancreatic cancer.

The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.

Since her mother died of pancreatic cancer, actress Keesha Sharp wants to teach others about the robust research on the disease’s treatment.

Experimental monoclonal antibody sotigalimab shows promising results in a Phase I study.

The Damon Runyon Cancer Research Foundation awards $2.8 million to innovative early career scientists.

The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.

Keesha Sharp has a message of hope about new research for people with pancreatic cancer.

Damon Runyon researchers are making an impact through understanding the biology and developing novel treatments.

November is National Pancreatic Cancer Awareness Month.

He battled Stage IV pancreatic cancer for 18 months.

Adagrasib targets a specific cancer-causing mutation, while VS-6766 interferes with multiple steps in a cell growth signaling pathway.

The Supreme Court justice died from complications of metastatic pancreatic cancer.

Close attention to the combination could lead to catching the cancer before it has metastasized.